Recursion Pharmaceuticals, Inc. presented a demonstration of LOWE (Large Language Model-Orchestrated Workflow Engine), its new software designed to perform complex drug discovery tasks using a natural language interface. LOWE is powered by Recursion?s proprietary biological and chemical data and can orchestrate experiments using Recursion?s automated wet laboratories, unleashing the power of the Recursion Operating System in an easy-to-use tool. Chris Gibson unveiled LOWE during Recursion?s presentation at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco.

On January 10, Recursion and NVIDIA will co-host an invite-only event featuring an exciting lineup of speakers and additional software demonstrations of LOWE. Speakers at the event will include Jensen Huang, Founder and CEO of NVIDIA, Martin Chavez, Partner and Vice Chairman at Sixth Street Capital and Chairman of Recursion, Aviv Regev, Head and Executive Vice President of Research and Early Development at Genentech, Scott Gottlieb, Senior Fellow at the American Enterprise Institute, and Amy Abernethy, President of Product Development and Chief Medical Officer at Verily.